Mastocitosi sistemica: con avapritinib nuove prospettive di cura con la medicina di precisione PharmaStar - 01 Mar 2024 Mastocitosi sistemica: con avapritinib nuove prospettive di cura con la medicina di precisione ... More
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on ... Nature - 12 Mar 2024 Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on ... ... More
Systemic Mastocytosis Workup: Approach Considerations, Laboratory Studies, Imaging Studies Medscape - 04 Mar 2024 Systemic Mastocytosis Workup: Approach Considerations, Laboratory Studies, Imaging Studies ... More
Bezuclastinib Improves Mast Cell Burden, TSS Vs Placebo in Nonadvanced Systemic Mastocytosis OncLive - 27 Feb 2024 Bezuclastinib Improves Mast Cell Burden, TSS Vs Placebo in Nonadvanced Systemic Mastocytosis ... More
A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis ... Nature - 06 Jan 2024 A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis ... ... More
Bezuclastinib was safe and rapidly lowered markers of disease burden for patients with nonadvanced systemic ... MD Anderson Cancer Center - 09 Dec 2023 Bezuclastinib was safe and rapidly lowered markers of disease burden for patients with nonadvanced systemic ... ... More
Blueprint Medicines' AYVAKYT® (avapritinib) Receives European Commission Approval as the First and Only ... PR Newswire - 12 Dec 2023 Blueprint Medicines' AYVAKYT® (avapritinib) Receives European Commission Approval as the First and Only ... ... More
Avapritinib Receives Support for Indolent Systemic Mastocytosis Indication in Europe Docwire News - 21 Nov 2023 Avapritinib Receives Support for Indolent Systemic Mastocytosis Indication in Europe ... More
EC approves Blueprint’s Ayvakyt as first treatment for rare haematological disorder PMLiVE - 14 Dec 2023 EC approves Blueprint’s Ayvakyt as first treatment for rare haematological disorder ... More
EC approves treatment for rare haematological disorder European Pharmaceutical Review - 13 Dec 2023 EC approves treatment for rare haematological disorder ... More
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full ... Financial Times - 02 May 2024 Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full ... ... More
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with ... Yahoo Finance - 22 Feb 2024 Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with ... ... More
Cogent Biosciences stock drops as analysts see tough competition for mastocytosis treatment MarketWatch - 11 Dec 2023 Cogent Biosciences stock drops as analysts see tough competition for mastocytosis treatment ... More
INTERNATIONAL MASTOCYTOSIS & MAST CELL DISEASE AWARENESS DAY | October 20 National Day Calendar - 27 Feb 2024 INTERNATIONAL MASTOCYTOSIS & MAST CELL DISEASE AWARENESS DAY | October 20 ... More
KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis OncLive - 26 Sep 2023 KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis ... More
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the ... Nature - 06 Mar 2024 Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the ... ... More
Fact or Fiction: Management of Systemic Mastocytosis - Page 4 Medscape - 04 Apr 2024 Fact or Fiction: Management of Systemic Mastocytosis - Page 4 ... More
Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH ... PR Newswire - 09 Dec 2023 Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH ... ... More
Europe Approves Avapritinib for Rare Mast Cell Disease Medscape - 13 Dec 2023 Europe Approves Avapritinib for Rare Mast Cell Disease ... More